Ginecología y Obstetricia de México

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Ginecología y Obstetricia de México >Year 2010, Issue 03

Flores-Carreras Ó, Martínez-Espinoza CJ, González-Ruiz MI, Montes-Casillas YE
Contribution bladder biopsy to the study of urogynaecological patient
Ginecol Obstet Mex 2010; 78 (03)

Language: Español
References: 9
Page: 187-190
PDF: 428.27 Kb.

Full text


Background: One of the characteristics of urinary symptoms in women is their lack of specificity. Patients with stress incontinence or urgency, local irritation, infection, distal stenosis or a neoplastic process have very similar symptoms.
Objective: Determine the frequency of bladder structural lesions detected by urethrocistoscopy in which we performed bladder biopsies.
Material and method: Descriptive, retrospective, analytical study of files and videos of 331 patients treated in Urodifem de Occidente (private Urogynecology Center). Thirty-five biopsies were taken. The statistical analysis was expressed as means standard deviations, ranges, percentages and Fishers test.
Results: Patients ages range 30-90 years average 60+13.76. Predominant symptoms were: irritative vesical syndrome 62.8%; pelvic pain 45.71%; urge incontinence 31.4%; hematuria 31.4%; vesical voiding dysfunction 11.4%. Principal endoscopic findings: Urethrotrigonitis; glomerular lesions or Hunner ulcers; vesical trabeculations; tumor or suspect lesions. Histopathologic findings were: Interstitial Cystitis 42.9%; chronic Cystitis 11.4%; Cystitis glandularis 8.6%; Cystitis follicular 11.4%; bladder cancer 5.7%; Vesical Papilloma 5.7%.
Conclusions: This study supports the practice of vesical biopsy when lesions other than those from chronic infection are observes in the presence of tumors or suspect lesions.

Key words: Bladder Biopsy, Bladder Dysfunction, Bladder suspect lesions, Urethrocistoscopy.


  1. Wu JM, Williams KS, Hundley AF, et al. Microscopic hematuria as a predictive factor for detecting bladder cancer and cystoscopy in women with irritative voiding symptoms. Amer J of Obstet Gynecol 2006;194:1423-1426.

  2. National Cancer Institute. Surveillance. Epidemiology and end Results (Seer) Program . [Accessed Oct 20, 2005].

  3. Jemal A, Murray T, Ward E, et al. Cancer Statistics 2005. CA Cancer J Clin 2005;55:10-30.

  4. Cundiff GW, Bent AE. The contribution of urethrocystoscopy to evaluation of lower urinary tract dysfunction in women. Int Urogynecol J 1996;7:307-311.

  5. Pashos CL, Botheman MF, Laskin BL, Redaelli A. Bladder cancer epidemiology, diagnosis and management. Cancer Pract 2002;10:311-322.

  6. Borden LS, Clark PE, Hall MC. Bladder cancer. Curr Opinion Oncol 2003;15:227-233.

  7. Sokoe ER, Patel SR, Sung VW, et al. Results of urine cytology testing and cystoscopy in women with irritative symptoms. Am J Obstet Gynecol 2005;192:1560-1565.

  8. Bryan RT, Nicholls JH, Harrison RF, et al. The role of betacatenin signaling in the malignant potential of cystitis glandularis. J Urol 2003;170(S):1892-1896.

  9. Sung MT, Lopez-Beltran A, Eble JN, et al. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol 2006;19(11):1395-1401.

>Journals >Ginecología y Obstetricia de México >Year 2010, Issue 03

· Journal Index 
· Links 

Copyright 2019